DiscoverInnovation AnsweredAct 1 of Corporate Innovation is Over — It's Time for Act 2
Act 1 of Corporate Innovation is Over — It's Time for Act 2

Act 1 of Corporate Innovation is Over — It's Time for Act 2

Update: 2024-01-09
Share

Description

"For too long," says Todd Dunn, "many organizations have not developed innovation as a strategic and ongoing source of competitive advantage. Instead, some organizations have used it for reputational points in the public eye, but not to deliver measurable value to consumers, customers and the company."

That's a big problem, argues Dunn, who was most recently the Vice President of Enterprise Innovation at Advocate Health. Advocate is headquartered in Charlotte, NC, and it’s the fifth biggest nonprofit health system in the US. 

In this episode, we talk with Dunn about what went wrong in Act 1 of corporate innovation — and what needs to change in Act 2. Our discussion was sparked by Dunn's recent LinkedIn piece, "Innovation: The Driving Force of Competitive Advantage."

You can subscribe to our podcast, “Innovation Answered,” on Spotify, iTunes, Stitcher, or Google Podcasts.

Scott Kirsner hosted this episode, and Hadley Thompson produced.

Comments 
loading
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Act 1 of Corporate Innovation is Over — It's Time for Act 2

Act 1 of Corporate Innovation is Over — It's Time for Act 2